OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy
Jie Pan, Lisha Zhou, Chenyang Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Recent Advances in 3D Printing of Smart Scaffolds for Bone Tissue Engineering and Regeneration
Xun Yuan, Wei Zhu, Zhongyuan Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 34
Closed Access | Times Cited: 48

Bioactive Components of Areca Nut: An Overview of Their Positive Impacts Targeting Different Organs
Huihui Sun, Wenzhen Yu, Hu Li, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 695-695
Open Access | Times Cited: 16

Role of natural products in tumor therapy from basic research and clinical perspectives
Zhisen Wang, Zhengcheng Liu, Jiao Qu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 16

Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders
Peng Yuan, Ruyi Qu, Shuqin Xu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24619-e24619
Open Access | Times Cited: 10

Protein tyrosine phosphatase 1B (PTP1B) function, structure, and inhibition strategies to develop antidiabetic drugs
Andrea Coronell‐Tovar, Juan Pablo Pardo, Adela Rodríguez‐Romero, et al.
FEBS Letters (2024)
Open Access | Times Cited: 10

Modulating the phosphorylation status of target proteins through bifunctional molecules
Qindi He, Zhijie Wang, Rongrong Wang, et al.
Drug Discovery Today (2025), pp. 104307-104307
Closed Access | Times Cited: 1

Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics
David B. Neale, Jonathan C. Morris, Nicole M. Verrills, et al.
Pharmacology & Therapeutics (2025), pp. 108834-108834
Closed Access | Times Cited: 1

Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment
Yan Lv, Mengyuan Li, Ling Weng, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13

Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases
Jiao Pang, Chang-Qian Cen, Tian Yuan, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access

Allostery in Disease: Anticancer Drugs, Pockets, and the Tumor Heterogeneity Challenge
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Journal of Molecular Biology (2025), pp. 169050-169050
Open Access

Phaseolus lunatus L. polysaccharide microneedles loaded with sinomenine hydrochloride for synergistic rheumatoid arthritis management and analgesia
Yanyan Feng, Yan Tang, Jingwen Hu, et al.
International Journal of Biological Macromolecules (2025), pp. 141511-141511
Closed Access

Betulonic acid: A review on its sources, biological activities, and molecular mechanisms
Shengying Lou, Chunyan Dai, Yuhua Wu, et al.
European Journal of Pharmacology (2025), pp. 177518-177518
Closed Access

Toxoplasma GRA16 attenuates tau hyperphosphorylation and enhances autophagy in thrombin-treated HT-22 hippocampal neuronal cells
Seung‐Hwan Seo, Do-Won Ham, Ji‐Eun Lee, et al.
Research Square (Research Square) (2025)
Closed Access

Inflammation-responsive nanoparticles suppress lymphatic clearance for prolonged arthritis therapy
Xianyan Qin, Li‐Hua Pan, Tao Chen, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 700-711
Closed Access | Times Cited: 19

Impact of inflammation and anti-inflammatory modalities on diabetic cardiomyopathy healing: From fundamental research to therapy
Xiaojiao Zhang, Xiao-Wei Han, Yanhui Jiang, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110747-110747
Closed Access | Times Cited: 12

Cognitive Impairment in Multiple Sclerosis
Kenneth Maiese
Bioengineering (2023) Vol. 10, Iss. 7, pp. 871-871
Open Access | Times Cited: 11

PP2A Attenuates Thoracic Aneurysm and Dissection in Mouse Models of Marfan Syndrome
Xianming Zhou, Qian Xu, Xingjian Hu, et al.
Hypertension (2025)
Closed Access

A Medicinal Chemistry Perspective on Protein Tyrosine Phosphatase Nonreceptor Type 2 in Tumor Immunology
Qi Huang, Linghao Hu, Hao Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery
Wentao Tang, Congcong Lin, Quanwei Yu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7140-7161
Closed Access | Times Cited: 9

Advances in small-molecule insulin secretagogues for diabetes treatment
Jingqian Su, Jingran Xu, Shan Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117179-117179
Open Access | Times Cited: 3

Insights into the post-translational modifications in heart failure
Xudong Zhang, Yan Wang, Huaping Li, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102467-102467
Closed Access | Times Cited: 3

Dual-specificity phosphatases 22-deficient T cells contribute to the pathogenesis of ankylosing spondylitis
Ming‐Han Chen, Huai‐Chia Chuang, Yi‐Chen Yeh, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top